Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial
Anna Kopczak(Mayo Clinic), Joanna M. Wardlaw(University of Edinburgh), Daniëlle Kerkhofs(Maastricht University), Maud van Dinther(Maastricht University Medical Centre), Fergus Doubal(University of Edinburgh), Peter M. Rothwell(UK Dementia Research Institute), Marie‐Germaine Bousser(Lund University), Geert Jan Biessels(University Medical Center Utrecht), Michael J. Thrippleton(MRC Centre for Regenerative Medicine), Saskia A.J. Lesnik Oberstein(Leiden University Medical Center), Daniela Jaime García(UK Dementia Research Institute), Keith W. Muir(University of Glasgow), Martin Middeke(Technologie- und Förderzentrum im Kompetenzzentrum für Nachwachsende Rohstoffe), Ulrich Mansmann(Zimmer Biomet (Netherlands)), Carmen Arteaga(UK Dementia Research Institute), Martin Dichgans(Munich Cluster for Systems Neurology), Julie Staals(Maastricht University), Agniete Kampaite(University of Edinburgh), Bo Norrving(Lund University), Hilde van den Brink(University Medical Center Utrecht), Gordon W. Blair(University of Edinburgh), Michael Stringer(UK Dementia Research Institute), Alastair J.S. Webb(Imperial College London), Marco Duering(LMU Klinikum), Robert van Oostenbrugge(Maastricht University), Laurien Onkenhout(University Medical Center Utrecht), Karolina Wartolowska(John Radcliffe Hospital)
Cited by 38
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k
Small vessel disease: mechanisms and clinical implications
|The Lancet Neurology|2019|1.7k